Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Pentair???s (PNR) Q4 Earnings In Line, Revenues Beat Estimates By Zacks Investment Research - Jan 29, 2018

Pentair Plc (NYSE:PNR) , a diversified industrial manufacturing company, reported fourth-quarter 2017 results, wherein adjusted earnings of 93 cents came in line with the Zacks Consensus Estimate....

Zacks Investment Research
International Paper (IP) Q4 Earnings: What's In The Offing? By Zacks Investment Research - Jan 29, 2018

Leading packaging and paper manufacturer International Paper Company (NYSE:IP) is scheduled to report fourth-quarter 2017 results before the opening bell on Feb 1. The company is likely to report...

Zacks Investment Research
Air Products Secures Supply Contracts From Samsung Display By Zacks Investment Research - Jan 29, 2018

Air Products and Chemicals Inc. (NYSE:APD) has secured new long-term supply deals from Samsung (KS:005930) Display. Per the contracts, the company will supply gaseous nitrogen and oxygen, and liquid...

Zacks Investment Research
What's In Store For Cardinal Health (CAH) In Q2 Earnings? By Zacks Investment Research - Jan 29, 2018

Cardinal Health (NYSE:CAH) is set to report second-quarter fiscal 2018 results on Feb 8, before the closing bell. The company’s innovative product line, strategic buyouts, joint ventures and...

Zacks Investment Research
Shell Vs. BP: Which Is A Better Buy Ahead Of Q4 Earnings? By Zacks Investment Research - Jan 29, 2018

Oil prices are possibly experiencing their best phase in several years at present. A confluence of factors has made this possible, including the fall in the dollar’s value, consistent declines...

Zacks Investment Research
Marathon (MPC) To Reward Shareholders With 15% Dividend Hike By Zacks Investment Research - Jan 29, 2018

The board of directors of Marathon Petroleum Corporation (NYSE:MPC) recently approved a 15% hike in its quarterly dividend. The company will now reward shareholders with a dividend of 46 cents per...

Zacks Investment Research
Aetna (AET) Q4 Earnings Beat, Revenues Miss Estimates By Zacks Investment Research - Jan 29, 2018

Have you been eager to see how Aetna Inc. (NYSE:AET) performed in Q4 in comparison with the market expectations? Let’s quickly scan through the key facts from this Hartford -based major health...

Zacks Investment Research
Group 1 Automotive Acquires A Couple Of Dealerships In Texas By Zacks Investment Research - Jan 29, 2018

Group 1 Automotive, Inc. (NYSE:GPI) has announced the acquisition of two dealerships in Texas in order to bolster its business presence. Both dealerships are located in El Paso, TX, catering two...

Zacks Investment Research
A.O. Smith (AOS) Q4 Earnings Beat, 2018 View Robust By Zacks Investment Research - Jan 29, 2018

A. O. Smith Corporation (NYSE:AOS) is one of the leading manufacturers of commercial and residential water heating equipment, as well as water treatment products of the world. The company...

Zacks Investment Research
Industrial Stocks' Earnings On Jan 31: JCI, IR, AVY, CMPR By Zacks Investment Research - Jan 29, 2018

The earnings season is off to a solid start with decent performance across the table. About 133 S&P 500 members have already released their results till Jan 26. Total earnings for these companies...

Zacks Investment Research
PulteGroup (PHM) Tops Q4 Earnings, Meets Revenue Estimates By Zacks Investment Research - Jan 29, 2018

PulteGroup Inc. (NYSE:PHM) is one of the leading homebuilders in the United States. The company caters to all major customer segments: first-time, move-up and active adult, in several markets across...

Zacks Investment Research
Buy 4 Wireless Equipment Stocks For Seamless Returns By Zacks Investment Research - Jan 29, 2018

U.S. telecommunications had a disappointing 2017. While the S&P 500 index gained 16.91% in 2017, the telecom service provider industry declined 0.73% and the telecom equipment manufacturer...

Zacks Investment Research
Pfizer (PFE) Q4 Earnings & Sales Top, 2018 View Upbeat By Zacks Investment Research - Jan 29, 2018

Pfizer Inc.’s (NYSE:PFE) is one of the most well-known names in the pharmaceutical sector not just for its medicines and vaccines but also for its consumer healthcare products. This New...

Continue with Apple
Continue with Google
or
Sign up with Email